Janiczek Wealth Management’s Amedisys AMED Stock Holding History

Janiczek Wealth Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$12.9K	Hold	141	–	–	﹤0.01%	626
2024 Q1	$13K	Hold	141	–	–	﹤0.01%	636
2023 Q4	$13.4K	Hold	141	–	–	﹤0.01%	619
2023 Q3	$13.2K	Hold	141	–	–	﹤0.01%	585
2023 Q2	$12.9K	Buy	141 +49	+53%	+$4.02K	﹤0.01%	532
2023 Q1	$7.46K	Buy	+92	New	+$7.96K	﹤0.01%	619
2022 Q2	–	Sell	-131	Closed	-$23K	–	935
2022 Q1	$23K	Buy	131 +105	+404%	+$15.7K	0.01%	423
2021 Q4	$4K	Sell	26 -25	-49%	-$4.02K	﹤0.01%	723
2021 Q3	$8K	Buy	51 +27	+113%	+$5.61K	﹤0.01%	602
2021 Q2	$6K	Sell	24 -69	-74%	-$18.1K	﹤0.01%	628
2021 Q1	$25K	Buy	93 +82	+745%	+$23.1K	0.01%	354
2020 Q4	$3K	Buy	11 +9	+450%	+$2.31K	﹤0.01%	642
2020 Q3	$0	Buy	+2	New	+$455	﹤0.01%	637

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Janiczek Wealth Management's AMED Position: Q2 2024 in Review

Janiczek Wealth Management held its Amedisys (AMED) position steady in Q2 2024 at 141 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Janiczek Wealth Management first reported a position in AMED in Q3 2020 and has held it in 13 quarters since. The position peaked at $25K in Q1 2021. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2024.

Janiczek Wealth Management held 141 shares of Amedisys worth $12.9K as of Q2 2024.
Janiczek Wealth Management left its Amedisys share count unchanged in Q2 2024.
Amedisys made up ﹤0.01% of Janiczek Wealth Management's portfolio in Q2 2024, its #626 holding.
Janiczek Wealth Management first reported a position in Amedisys in Q3 2020 and has held it in 13 quarters since.
Janiczek Wealth Management's Amedisys position peaked at $25K in Q1 2021.
288 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.